Sanofi To Lay Off 229 Blueprint Medicines Staffers, Close Cambridge Offices
Sanofi is laying off 229 Blueprint Medicines staffers and closing the company's Cambridge offices following its acquisition, according to a FiercePharma report. Kate Haviland, formerly Blueprint's CEO, has since taken the board chair role at GC Therapeutics, a Cambridge-based cell thera…